Eyeforpharma in a recent article breaks down what it says are the top trends in the pharmaceutical sector as we kick off the new year.
Its No. 1 top trend involves drug pricing and the affordability of health care amid concerns about how consumers are handling the high costs.
“I foresee further downward pressure on prices heading our way,” MSD Patient Innovation European Lead Paul Robinson says. “We will see money diverted to social care, away from acute medicine, driven by the wave of highly innovative but costly new drugs especially in cancer, gene therapy, etc.”
To read the full report on eyeforpharma, click here.
